APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tenofovir Disoproxil Fumarate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tenofovir Disoproxil Fumarate Tablets Market Analysis and Forecast 2026-2032

29 December 2025206 pages

Choose your research edition.

Industry ResearchTenofovir Disoproxil Fumarate Tablets Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Tenofovir Disoproxil Fumarate Tablets Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Tenofovir Disoproxil Fumarate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tenofovir Disoproxil Fumarate Tablets Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Tenofovir Disoproxil Fumarate Tablets Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Tenofovir Disoproxil Fumarate Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tenofovir Disoproxil Fumarate Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tenofovir Disoproxil Fumarate Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tenofovir Disoproxil Fumarate Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tenofovir Disoproxil Fumarate Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tenofovir Disoproxil Fumarate Tablets include Aurobindo Pharma, Gilead Sciences, GSK, Hetero Drugs, Strides Pharma, Teva Pharmaceuticals, Chengdu Beite Pharmaceutical, Haisco Pharmaceutical and Shijiazhuang Lonzeal Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tenofovir Disoproxil Fumarate Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tenofovir Disoproxil Fumarate Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Tenofovir Disoproxil Fumarate Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tenofovir Disoproxil Fumarate Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tenofovir Disoproxil Fumarate Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tenofovir Disoproxil Fumarate Tablets sales, projected growth trends, production technology, application and end-user industry.

Tenofovir Disoproxil Fumarate Tablets Segment by Company

Aurobindo Pharma

Gilead Sciences

GSK

Hetero Drugs

Strides Pharma

Teva Pharmaceuticals

Chengdu Beite Pharmaceutical

Haisco Pharmaceutical

Shijiazhuang Lonzeal Pharmaceuticals

Luoxin Pharmaceuticals

Qilu Pharmaceutical

Shanghai Haini Pharmaceutical

Beijing SL Pharmaceutical

Sichuan Kelun Pharmaceutical

Chongqing Yaoyou Pharmaceutical

Zhejiang Sukean Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Tenofovir Disoproxil Fumarate Tablets Segment by Type

Original Drug

Generic Drug

Tenofovir Disoproxil Fumarate Tablets Segment by Application

HIV-1 Infection

Chronic Hepatitis B

Tenofovir Disoproxil Fumarate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tenofovir Disoproxil Fumarate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tenofovir Disoproxil Fumarate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tenofovir Disoproxil Fumarate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tenofovir Disoproxil Fumarate Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tenofovir Disoproxil Fumarate Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tenofovir Disoproxil Fumarate Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Original Drug Major Manufacturers Table 3. Generic Drug Major Manufacturers Table 4. Global Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. HIV-1 Infection Major Manufacturers Table 6. Chronic Hepatitis B Major Manufacturers Table 7. Tenofovir Disoproxil Fumarate Tablets Industry Trends Table 8. Tenofovir Disoproxil Fumarate Tablets Industry Drivers Table 9. Tenofovir Disoproxil Fumarate Tablets Industry Opportunities and Challenges Table 10. Tenofovir Disoproxil Fumarate Tablets Industry Restraints Table 11. Global Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Region (2021-2026) Table 15. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Region (2027-2032) Table 16. Global Tenofovir Disoproxil Fumarate Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Tenofovir Disoproxil Fumarate Tablets Sales by Region (2021-2026) & (K Units) Table 18. Global Tenofovir Disoproxil Fumarate Tablets Sales by Region (2027-2032) & (K Units) Table 19. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Region (2021-2026) Table 20. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Region (2027-2032) Table 21. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Tenofovir Disoproxil Fumarate Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Manufacturers (2021-2026) Table 25. Global Tenofovir Disoproxil Fumarate Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Tenofovir Disoproxil Fumarate Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Tenofovir Disoproxil Fumarate Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Tenofovir Disoproxil Fumarate Tablets Manufacturers, Product Type & Application Table 29. Global Tenofovir Disoproxil Fumarate Tablets Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Tenofovir Disoproxil Fumarate Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Type (2021-2026) Table 36. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Type (2027-2032) Table 37. Global Tenofovir Disoproxil Fumarate Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 39. Global Tenofovir Disoproxil Fumarate Tablets Sales by Type (2027-2032) & (K Units) Table 40. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Type (2021-2026) Table 41. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Type (2027-2032) Table 42. Global Tenofovir Disoproxil Fumarate Tablets Price by Type (2021-2026) & (US$/Unit) Table 43. Global Tenofovir Disoproxil Fumarate Tablets Price by Type (2027-2032) & (US$/Unit) Table 44. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Application (2021-2026) Table 48. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Application (2027-2032) Table 49. Global Tenofovir Disoproxil Fumarate Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 51. Global Tenofovir Disoproxil Fumarate Tablets Sales by Application (2027-2032) & (K Units) Table 52. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Application (2021-2026) Table 53. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Application (2027-2032) Table 54. Global Tenofovir Disoproxil Fumarate Tablets Price by Application (2021-2026) & (US$/Unit) Table 55. Global Tenofovir Disoproxil Fumarate Tablets Price by Application (2027-2032) & (US$/Unit) Table 56. Aurobindo Pharma Company Information Table 57. Aurobindo Pharma Business Overview Table 58. Aurobindo Pharma Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Aurobindo Pharma Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 60. Aurobindo Pharma Recent Development Table 61. Gilead Sciences Company Information Table 62. Gilead Sciences Business Overview Table 63. Gilead Sciences Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Gilead Sciences Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 65. Gilead Sciences Recent Development Table 66. GSK Company Information Table 67. GSK Business Overview Table 68. GSK Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. GSK Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 70. GSK Recent Development Table 71. Hetero Drugs Company Information Table 72. Hetero Drugs Business Overview Table 73. Hetero Drugs Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Hetero Drugs Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 75. Hetero Drugs Recent Development Table 76. Strides Pharma Company Information Table 77. Strides Pharma Business Overview Table 78. Strides Pharma Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Strides Pharma Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 80. Strides Pharma Recent Development Table 81. Teva Pharmaceuticals Company Information Table 82. Teva Pharmaceuticals Business Overview Table 83. Teva Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Teva Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 85. Teva Pharmaceuticals Recent Development Table 86. Chengdu Beite Pharmaceutical Company Information Table 87. Chengdu Beite Pharmaceutical Business Overview Table 88. Chengdu Beite Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Chengdu Beite Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 90. Chengdu Beite Pharmaceutical Recent Development Table 91. Haisco Pharmaceutical Company Information Table 92. Haisco Pharmaceutical Business Overview Table 93. Haisco Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Haisco Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 95. Haisco Pharmaceutical Recent Development Table 96. Shijiazhuang Lonzeal Pharmaceuticals Company Information Table 97. Shijiazhuang Lonzeal Pharmaceuticals Business Overview Table 98. Shijiazhuang Lonzeal Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shijiazhuang Lonzeal Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 100. Shijiazhuang Lonzeal Pharmaceuticals Recent Development Table 101. Luoxin Pharmaceuticals Company Information Table 102. Luoxin Pharmaceuticals Business Overview Table 103. Luoxin Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Luoxin Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 105. Luoxin Pharmaceuticals Recent Development Table 106. Qilu Pharmaceutical Company Information Table 107. Qilu Pharmaceutical Business Overview Table 108. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 110. Qilu Pharmaceutical Recent Development Table 111. Shanghai Haini Pharmaceutical Company Information Table 112. Shanghai Haini Pharmaceutical Business Overview Table 113. Shanghai Haini Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Shanghai Haini Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 115. Shanghai Haini Pharmaceutical Recent Development Table 116. Beijing SL Pharmaceutical Company Information Table 117. Beijing SL Pharmaceutical Business Overview Table 118. Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 120. Beijing SL Pharmaceutical Recent Development Table 121. Sichuan Kelun Pharmaceutical Company Information Table 122. Sichuan Kelun Pharmaceutical Business Overview Table 123. Sichuan Kelun Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sichuan Kelun Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 125. Sichuan Kelun Pharmaceutical Recent Development Table 126. Chongqing Yaoyou Pharmaceutical Company Information Table 127. Chongqing Yaoyou Pharmaceutical Business Overview Table 128. Chongqing Yaoyou Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Chongqing Yaoyou Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 130. Chongqing Yaoyou Pharmaceutical Recent Development Table 131. Zhejiang Sukean Pharmaceutical Company Information Table 132. Zhejiang Sukean Pharmaceutical Business Overview Table 133. Zhejiang Sukean Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Zhejiang Sukean Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 135. Zhejiang Sukean Pharmaceutical Recent Development Table 136. Chia Tai Tianqing Pharmaceutical Company Information Table 137. Chia Tai Tianqing Pharmaceutical Business Overview Table 138. Chia Tai Tianqing Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Chia Tai Tianqing Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 140. Chia Tai Tianqing Pharmaceutical Recent Development Table 141. North America Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 142. North America Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 143. North America Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 144. North America Tenofovir Disoproxil Fumarate Tablets Sales by Type (2027-2032) & (K Units) Table 145. North America Tenofovir Disoproxil Fumarate Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 146. North America Tenofovir Disoproxil Fumarate Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 147. North America Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 148. North America Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 149. North America Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 150. North America Tenofovir Disoproxil Fumarate Tablets Sales by Application (2027-2032) & (K Units) Table 151. North America Tenofovir Disoproxil Fumarate Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 152. North America Tenofovir Disoproxil Fumarate Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 153. North America Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. North America Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. North America Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 157. North America Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 158. North America Tenofovir Disoproxil Fumarate Tablets Sales by Country (2027-2032) & (K Units) Table 159. North America Tenofovir Disoproxil Fumarate Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 160. North America Tenofovir Disoproxil Fumarate Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 161. United States Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 162. Canada Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 163. Mexico Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 164. Europe Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 165. Europe Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 166. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 167. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Type (2027-2032) & (K Units) Table 168. Europe Tenofovir Disoproxil Fumarate Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Europe Tenofovir Disoproxil Fumarate Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Europe Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 171. Europe Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 172. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 173. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Application (2027-2032) & (K Units) Table 174. Europe Tenofovir Disoproxil Fumarate Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Europe Tenofovir Disoproxil Fumarate Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Europe Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Europe Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Europe Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 181. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Country (2027-2032) & (K Units) Table 182. Europe Tenofovir Disoproxil Fumarate Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Europe Tenofovir Disoproxil Fumarate Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Germany Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 185. France Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 186. U.K. Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 187. Italy Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 188. Russia Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 189. Spain Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 190. Netherlands Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 191. Switzerland Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 192. Sweden Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 193. Poland Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 194. China Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 195. China Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 196. China Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 197. China Tenofovir Disoproxil Fumarate Tablets Sales by Type (2027-2032) & (K Units) Table 198. China Tenofovir Disoproxil Fumarate Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 199. China Tenofovir Disoproxil Fumarate Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 200. China Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 201. China Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 202. China Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 203. China Tenofovir Disoproxil Fumarate Tablets Sales by Application (2027-2032) & (K Units) Table 204. China Tenofovir Disoproxil Fumarate Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 205. China Tenofovir Disoproxil Fumarate Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 207. Asia Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 208. Asia Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 209. Asia Tenofovir Disoproxil Fumarate Tablets Sales by Type (2027-2032) & (K Units) Table 210. Asia Tenofovir Disoproxil Fumarate Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 211. Asia Tenofovir Disoproxil Fumarate Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 212. Asia Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 213. Asia Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 214. Asia Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 215. Asia Tenofovir Disoproxil Fumarate Tablets Sales by Application (2027-2032) & (K Units) Table 216. Asia Tenofovir Disoproxil Fumarate Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 217. Asia Tenofovir Disoproxil Fumarate Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 218. Asia Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. Asia Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. Asia Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. Asia Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 222. Asia Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 223. Asia Tenofovir Disoproxil Fumarate Tablets Sales by Country (2027-2032) & (K Units) Table 224. Asia Tenofovir Disoproxil Fumarate Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 225. Asia Tenofovir Disoproxil Fumarate Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 226. Japan Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 227. South Korea Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 228. India Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 229. Australia Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 230. Taiwan Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 231. Southeast Asia Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 232. SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 233. SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 234. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 235. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales by Type (2027-2032) & (K Units) Table 236. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 237. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 238. SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 239. SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 240. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 241. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales by Application (2027-2032) & (K Units) Table 242. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 243. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 244. SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 248. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 249. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales by Country (2027-2032) & (K Units) Table 250. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 251. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 252. Brazil Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 253. Argentina Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 254. Chile Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 255. Colombia Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 256. Peru Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 257. Saudi Arabia Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 258. Israel Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 259. UAE Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 260. Turkey Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 261. Iran Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 262. Egypt Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Table 263. Key Raw Materials Table 264. Raw Materials Key Suppliers Table 265. Tenofovir Disoproxil Fumarate Tablets Distributors List Table 266. Tenofovir Disoproxil Fumarate Tablets Customers List Table 267. Research Programs/Design for This Report Table 268. Authors List of This Report Table 269. Secondary Sources Table 270. Primary Sources List of Figures Figure 1. Tenofovir Disoproxil Fumarate Tablets Image Figure 2. Global Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tenofovir Disoproxil Fumarate Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. Original Drug Image Figure 5. Generic Drug Image Figure 6. Global Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Tenofovir Disoproxil Fumarate Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. HIV-1 Infection Image Figure 9. Chronic Hepatitis B Image Figure 10. Global Tenofovir Disoproxil Fumarate Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2032) & (US$ Million) Figure 12. Global Tenofovir Disoproxil Fumarate Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Region (2021-2032) Figure 15. Global Tenofovir Disoproxil Fumarate Tablets Sales (2021-2032) & (K Units) Figure 16. Global Tenofovir Disoproxil Fumarate Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Tenofovir Disoproxil Fumarate Tablets Sales YoY (2021-2032) & (K Units) Figure 19. Europe Tenofovir Disoproxil Fumarate Tablets Sales YoY (2021-2032) & (K Units) Figure 20. China Tenofovir Disoproxil Fumarate Tablets Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Tenofovir Disoproxil Fumarate Tablets Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales YoY (2021-2032) & (K Units) Figure 23. Global Tenofovir Disoproxil Fumarate Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Tenofovir Disoproxil Fumarate Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Type (2021-2032) Figure 29. Global Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Type (2021-2032) Figure 32. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Application (2021-2032) Figure 35. Global Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Application (2021-2032) Figure 38. North America Tenofovir Disoproxil Fumarate Tablets Revenue Share by Type (2021-2032) Figure 39. North America Tenofovir Disoproxil Fumarate Tablets Sales Share by Type (2021-2032) Figure 40. North America Tenofovir Disoproxil Fumarate Tablets Revenue Share by Application (2021-2032) Figure 41. North America Tenofovir Disoproxil Fumarate Tablets Sales Share by Application (2021-2032) Figure 42. North America Tenofovir Disoproxil Fumarate Tablets Revenue Share by Country (2021-2032) Figure 43. North America Tenofovir Disoproxil Fumarate Tablets Sales Share by Country (2021-2032) Figure 44. Europe Tenofovir Disoproxil Fumarate Tablets Revenue Share by Type (2021-2032) Figure 45. Europe Tenofovir Disoproxil Fumarate Tablets Sales Share by Type (2021-2032) Figure 46. Europe Tenofovir Disoproxil Fumarate Tablets Revenue Share by Application (2021-2032) Figure 47. Europe Tenofovir Disoproxil Fumarate Tablets Sales Share by Application (2021-2032) Figure 48. Europe Tenofovir Disoproxil Fumarate Tablets Revenue Share by Country (2021-2032) Figure 49. Europe Tenofovir Disoproxil Fumarate Tablets Sales Share by Country (2021-2032) Figure 50. China Tenofovir Disoproxil Fumarate Tablets Revenue Share by Type (2021-2032) Figure 51. China Tenofovir Disoproxil Fumarate Tablets Sales Share by Type (2021-2032) Figure 52. China Tenofovir Disoproxil Fumarate Tablets Revenue Share by Application (2021-2032) Figure 53. China Tenofovir Disoproxil Fumarate Tablets Sales Share by Application (2021-2032) Figure 54. Asia Tenofovir Disoproxil Fumarate Tablets Revenue Share by Type (2021-2032) Figure 55. Asia Tenofovir Disoproxil Fumarate Tablets Sales Share by Type (2021-2032) Figure 56. Asia Tenofovir Disoproxil Fumarate Tablets Revenue Share by Application (2021-2032) Figure 57. Asia Tenofovir Disoproxil Fumarate Tablets Sales Share by Application (2021-2032) Figure 58. Asia Tenofovir Disoproxil Fumarate Tablets Revenue Share by Country (2021-2032) Figure 59. Asia Tenofovir Disoproxil Fumarate Tablets Sales Share by Country (2021-2032) Figure 60. SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue Share by Type (2021-2032) Figure 61. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales Share by Type (2021-2032) Figure 62. SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue Share by Application (2021-2032) Figure 63. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales Share by Application (2021-2032) Figure 64. SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue Share by Country (2021-2032) Figure 65. SAMEA Tenofovir Disoproxil Fumarate Tablets Sales Share by Country (2021-2032) Figure 66

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • HIV-1 Infection
  • Chronic Hepatitis B
Companies covered
  • Aurobindo Pharma
  • Gilead Sciences
  • GSK
  • Hetero Drugs
  • Strides Pharma
  • Teva Pharmaceuticals
  • Chengdu Beite Pharmaceutical
  • Haisco Pharmaceutical
  • Shijiazhuang Lonzeal Pharmaceuticals
  • Luoxin Pharmaceuticals
  • Qilu Pharmaceutical
  • Shanghai Haini Pharmaceutical
  • Beijing SL Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Chongqing Yaoyou Pharmaceutical
  • Zhejiang Sukean Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tenofovir Disoproxil Fumarate Tablets Market by Type
  3. 1.2.1 Global Tenofovir Disoproxil Fumarate Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Original Drug
  5. 1.2.3 Generic Drug
  6. 1.3 Tenofovir Disoproxil Fumarate Tablets Market by Application
  7. 1.3.1 Global Tenofovir Disoproxil Fumarate Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 HIV-1 Infection
  9. 1.3.3 Chronic Hepatitis B
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Tenofovir Disoproxil Fumarate Tablets Market Dynamics
  1. 2.1 Tenofovir Disoproxil Fumarate Tablets Industry Trends
  2. 2.2 Tenofovir Disoproxil Fumarate Tablets Industry Drivers
  3. 2.3 Tenofovir Disoproxil Fumarate Tablets Industry Opportunities and Challenges
  4. 2.4 Tenofovir Disoproxil Fumarate Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tenofovir Disoproxil Fumarate Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Region
  3. 3.2.1 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tenofovir Disoproxil Fumarate Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tenofovir Disoproxil Fumarate Tablets Sales by Region
  9. 3.4.1 Global Tenofovir Disoproxil Fumarate Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tenofovir Disoproxil Fumarate Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Tenofovir Disoproxil Fumarate Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Manufacturers
  2. 4.1.1 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tenofovir Disoproxil Fumarate Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tenofovir Disoproxil Fumarate Tablets Sales by Manufacturers
  6. 4.2.1 Global Tenofovir Disoproxil Fumarate Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tenofovir Disoproxil Fumarate Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tenofovir Disoproxil Fumarate Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tenofovir Disoproxil Fumarate Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tenofovir Disoproxil Fumarate Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tenofovir Disoproxil Fumarate Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Tenofovir Disoproxil Fumarate Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tenofovir Disoproxil Fumarate Tablets Market CR5 and HHI
  16. 4.8.2 2025 Tenofovir Disoproxil Fumarate Tablets Tier 1, Tier 2, and Tier 3
5 Tenofovir Disoproxil Fumarate Tablets Market by Type
  1. 5.1 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Type
  2. 5.1.1 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tenofovir Disoproxil Fumarate Tablets Sales by Type
  6. 5.2.1 Global Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tenofovir Disoproxil Fumarate Tablets Price by Type
6 Tenofovir Disoproxil Fumarate Tablets Market by Application
  1. 6.1 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Application
  2. 6.1.1 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tenofovir Disoproxil Fumarate Tablets Sales by Application
  6. 6.2.1 Global Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tenofovir Disoproxil Fumarate Tablets Price by Application
7 Company Profiles
  1. 7.1 Aurobindo Pharma
  2. 7.1.1 Aurobindo Pharma Company Information
  3. 7.1.2 Aurobindo Pharma Business Overview
  4. 7.1.3 Aurobindo Pharma Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aurobindo Pharma Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  6. 7.1.5 Aurobindo Pharma Recent Developments
  7. 7.2 Gilead Sciences
  8. 7.2.1 Gilead Sciences Company Information
  9. 7.2.2 Gilead Sciences Business Overview
  10. 7.2.3 Gilead Sciences Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Gilead Sciences Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  12. 7.2.5 Gilead Sciences Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GSK Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Hetero Drugs
  20. 7.4.1 Hetero Drugs Company Information
  21. 7.4.2 Hetero Drugs Business Overview
  22. 7.4.3 Hetero Drugs Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hetero Drugs Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  24. 7.4.5 Hetero Drugs Recent Developments
  25. 7.5 Strides Pharma
  26. 7.5.1 Strides Pharma Company Information
  27. 7.5.2 Strides Pharma Business Overview
  28. 7.5.3 Strides Pharma Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Strides Pharma Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  30. 7.5.5 Strides Pharma Recent Developments
  31. 7.6 Teva Pharmaceuticals
  32. 7.6.1 Teva Pharmaceuticals Company Information
  33. 7.6.2 Teva Pharmaceuticals Business Overview
  34. 7.6.3 Teva Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Teva Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  36. 7.6.5 Teva Pharmaceuticals Recent Developments
  37. 7.7 Chengdu Beite Pharmaceutical
  38. 7.7.1 Chengdu Beite Pharmaceutical Company Information
  39. 7.7.2 Chengdu Beite Pharmaceutical Business Overview
  40. 7.7.3 Chengdu Beite Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Chengdu Beite Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  42. 7.7.5 Chengdu Beite Pharmaceutical Recent Developments
  43. 7.8 Haisco Pharmaceutical
  44. 7.8.1 Haisco Pharmaceutical Company Information
  45. 7.8.2 Haisco Pharmaceutical Business Overview
  46. 7.8.3 Haisco Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Haisco Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  48. 7.8.5 Haisco Pharmaceutical Recent Developments
  49. 7.9 Shijiazhuang Lonzeal Pharmaceuticals
  50. 7.9.1 Shijiazhuang Lonzeal Pharmaceuticals Company Information
  51. 7.9.2 Shijiazhuang Lonzeal Pharmaceuticals Business Overview
  52. 7.9.3 Shijiazhuang Lonzeal Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Shijiazhuang Lonzeal Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  54. 7.9.5 Shijiazhuang Lonzeal Pharmaceuticals Recent Developments
  55. 7.10 Luoxin Pharmaceuticals
  56. 7.10.1 Luoxin Pharmaceuticals Company Information
  57. 7.10.2 Luoxin Pharmaceuticals Business Overview
  58. 7.10.3 Luoxin Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Luoxin Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  60. 7.10.5 Luoxin Pharmaceuticals Recent Developments
  61. 7.11 Qilu Pharmaceutical
  62. 7.11.1 Qilu Pharmaceutical Company Information
  63. 7.11.2 Qilu Pharmaceutical Business Overview
  64. 7.11.3 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  66. 7.11.5 Qilu Pharmaceutical Recent Developments
  67. 7.12 Shanghai Haini Pharmaceutical
  68. 7.12.1 Shanghai Haini Pharmaceutical Company Information
  69. 7.12.2 Shanghai Haini Pharmaceutical Business Overview
  70. 7.12.3 Shanghai Haini Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Shanghai Haini Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  72. 7.12.5 Shanghai Haini Pharmaceutical Recent Developments
  73. 7.13 Beijing SL Pharmaceutical
  74. 7.13.1 Beijing SL Pharmaceutical Company Information
  75. 7.13.2 Beijing SL Pharmaceutical Business Overview
  76. 7.13.3 Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  78. 7.13.5 Beijing SL Pharmaceutical Recent Developments
  79. 7.14 Sichuan Kelun Pharmaceutical
  80. 7.14.1 Sichuan Kelun Pharmaceutical Company Information
  81. 7.14.2 Sichuan Kelun Pharmaceutical Business Overview
  82. 7.14.3 Sichuan Kelun Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sichuan Kelun Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  84. 7.14.5 Sichuan Kelun Pharmaceutical Recent Developments
  85. 7.15 Chongqing Yaoyou Pharmaceutical
  86. 7.15.1 Chongqing Yaoyou Pharmaceutical Company Information
  87. 7.15.2 Chongqing Yaoyou Pharmaceutical Business Overview
  88. 7.15.3 Chongqing Yaoyou Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Chongqing Yaoyou Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  90. 7.15.5 Chongqing Yaoyou Pharmaceutical Recent Developments
  91. 7.16 Zhejiang Sukean Pharmaceutical
  92. 7.16.1 Zhejiang Sukean Pharmaceutical Company Information
  93. 7.16.2 Zhejiang Sukean Pharmaceutical Business Overview
  94. 7.16.3 Zhejiang Sukean Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Zhejiang Sukean Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  96. 7.16.5 Zhejiang Sukean Pharmaceutical Recent Developments
  97. 7.17 Chia Tai Tianqing Pharmaceutical
  98. 7.17.1 Chia Tai Tianqing Pharmaceutical Company Information
  99. 7.17.2 Chia Tai Tianqing Pharmaceutical Business Overview
  100. 7.17.3 Chia Tai Tianqing Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Chia Tai Tianqing Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  102. 7.17.5 Chia Tai Tianqing Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Tenofovir Disoproxil Fumarate Tablets Market Size by Type
  2. 8.1.1 North America Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Tenofovir Disoproxil Fumarate Tablets Price by Type (2021-2032)
  5. 8.2 North America Tenofovir Disoproxil Fumarate Tablets Market Size by Application
  6. 8.2.1 North America Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Tenofovir Disoproxil Fumarate Tablets Price by Application (2021-2032)
  9. 8.3 North America Tenofovir Disoproxil Fumarate Tablets Market Size by Country
  10. 8.3.1 North America Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tenofovir Disoproxil Fumarate Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Tenofovir Disoproxil Fumarate Tablets Market Size by Type
  2. 9.1.1 Europe Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Tenofovir Disoproxil Fumarate Tablets Price by Type (2021-2032)
  5. 9.2 Europe Tenofovir Disoproxil Fumarate Tablets Market Size by Application
  6. 9.2.1 Europe Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Tenofovir Disoproxil Fumarate Tablets Price by Application (2021-2032)
  9. 9.3 Europe Tenofovir Disoproxil Fumarate Tablets Market Size by Country
  10. 9.3.1 Europe Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tenofovir Disoproxil Fumarate Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Tenofovir Disoproxil Fumarate Tablets Market Size by Type
  2. 10.1.1 China Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Tenofovir Disoproxil Fumarate Tablets Price by Type (2021-2032)
  5. 10.2 China Tenofovir Disoproxil Fumarate Tablets Market Size by Application
  6. 10.2.1 China Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Tenofovir Disoproxil Fumarate Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tenofovir Disoproxil Fumarate Tablets Market Size by Type
  2. 11.1.1 Asia Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Tenofovir Disoproxil Fumarate Tablets Price by Type (2021-2032)
  5. 11.2 Asia Tenofovir Disoproxil Fumarate Tablets Market Size by Application
  6. 11.2.1 Asia Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Tenofovir Disoproxil Fumarate Tablets Price by Application (2021-2032)
  9. 11.3 Asia Tenofovir Disoproxil Fumarate Tablets Market Size by Country
  10. 11.3.1 Asia Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tenofovir Disoproxil Fumarate Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tenofovir Disoproxil Fumarate Tablets Market Size by Type
  2. 12.1.1 SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tenofovir Disoproxil Fumarate Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Tenofovir Disoproxil Fumarate Tablets Market Size by Application
  6. 12.2.1 SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tenofovir Disoproxil Fumarate Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Tenofovir Disoproxil Fumarate Tablets Market Size by Country
  10. 12.3.1 SAMEA Tenofovir Disoproxil Fumarate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tenofovir Disoproxil Fumarate Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tenofovir Disoproxil Fumarate Tablets Value Chain Analysis
  2. 13.1.1 Tenofovir Disoproxil Fumarate Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tenofovir Disoproxil Fumarate Tablets Production Mode & Process
  6. 13.2 Tenofovir Disoproxil Fumarate Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tenofovir Disoproxil Fumarate Tablets Distributors
  9. 13.2.3 Tenofovir Disoproxil Fumarate Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst